FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2117697211> ?p ?o ?g. }

• W2117697211 endingPage "573" @default.
• W2117697211 startingPage "566" @default.
• W2117697211 abstract "The in vitro activity of FK-037, 5-amino-2-[[(6R, 7R)-7-[[(Z)-2-(2-amino-4-thiazolyl)-2- methoxyimino) acetyl] amino]-2-carboxy-8-oxo-5-thia-1- azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-(2-hydroxyethyl)-1H-pyrazoli um hydroxide, inner salt, sulfate (1:1), a new parenteral cephem, was compared with those of cefepime, ceftazidime, imipenem, and ciprofloxacin. FK-037 inhibited methicillin-susceptible staphylocci at < or = 4 micrograms/ml. Of 98 isolates of homogenous methicillin-resistant Staphylococcus aureus, 55 (56.1%) were inhibited by 8 micrograms of FK-037 per ml, compared to 3.1% for cefepime. Imipenem was the most active beta-lactam tested against staphylococci. The MIC of FK-037 for 90% of the strains tested (MIC90) was 0.06 micrograms/ml for hemolytic streptococci, Streptococcus pneumoniae, viridans group streptococci, and Streptococcus bovis. The MIC90 for many of the members of the family Enterobacteriaceae was 1 microgram/ml, similar to that of cefepime and lower than those of ceftazidime and imipenem. The MIC90 for Klebsiella pneumoniae and Enterobacter cloacae was 8 micrograms/ml, similar to that for cefepime, but all isolates were inhibited by 2 micrograms of imipenem per ml. K. pneumoniae isolates with cefotaxime and ceftazidime MICs of > 32 micrograms/ml with Bush type 2b' beta-lactamases were inhibited by 4 micrograms of FK-037 per ml. E. cloacae, Citrobacter freundii, and S. aureus stably resistant to FK-037 could be selected by repeated transfer in the presence of FK-037. The FK-037 MIC90 for Pseudomonas aeruginosa was 4 microgram/ml, compared to 32 microgram/ml for cefepime and ceftazidime and 8 microgram/ml for imipenem. Xanthomonas maltophilia, Pseudomonas cepacia, Acinetobacter anitratus, and Bacteroides species were resistant to FK-037 (MIC, more than or equal 32 microgram/ml). MBCs were identical to or within twofold of the MICs except for a 32-fold greater MBC for P. aeruginosa. Inoculum size and acid environment did not lower the activity of FK-037. FK-037 was not appreciably hydrolyzed by Bush group 1, 2a, 2b, and 2e beta-lactamases but was hydrolyzed by 2b' and 2d enzymes at rates comparable to that of ceftazidime. Nonetheless, FK-037 inhibited bacteria possessing TEM-3, -5, and -7 and SHV -5 at less than or equal 8 microgram/ml. Overall, FK-037 has lower MICs against staphylococci and P. aeruginosa than the currently available iminomethoxy aminothiazolyl cephalosporins and has activity against members of the family Enterobacteriaceae comparable to that of cefepime." @default.
• W2117697211 created "2016-06-24" @default.
• W2117697211 creator A5003024911 @default.
• W2117697211 creator A5005831050 @default.
• W2117697211 creator A5065663137 @default.
• W2117697211 date "1993-03-01" @default.
• W2117697211 modified "2023-10-16" @default.
• W2117697211 title "In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin" @default.
• W2117697211 cites W2030371182 @default.
• W2117697211 cites W2077490313 @default.
• W2117697211 cites W2116649852 @default.
• W2117697211 doi "https://doi.org/10.1128/aac.37.3.566" @default.
• W2117697211 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/187708" @default.
• W2117697211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8460925" @default.
• W2117697211 hasPublicationYear "1993" @default.
• W2117697211 type Work @default.
• W2117697211 sameAs 2117697211 @default.
• W2117697211 citedByCount "29" @default.
• W2117697211 countsByYear W21176972112012 @default.
• W2117697211 countsByYear W21176972112014 @default.
• W2117697211 countsByYear W21176972112015 @default.
• W2117697211 countsByYear W21176972112021 @default.
• W2117697211 crossrefType "journal-article" @default.
• W2117697211 hasAuthorship W2117697211A5003024911 @default.
• W2117697211 hasAuthorship W2117697211A5005831050 @default.
• W2117697211 hasAuthorship W2117697211A5065663137 @default.
• W2117697211 hasBestOaLocation W21176972112 @default.
• W2117697211 hasConcept C104317684 @default.
• W2117697211 hasConcept C185592680 @default.
• W2117697211 hasConcept C2776968632 @default.
• W2117697211 hasConcept C2777050379 @default.
• W2117697211 hasConcept C2777058267 @default.
• W2117697211 hasConcept C2777402170 @default.
• W2117697211 hasConcept C2777637488 @default.
• W2117697211 hasConcept C2778709256 @default.
• W2117697211 hasConcept C2778719061 @default.
• W2117697211 hasConcept C2778752919 @default.
• W2117697211 hasConcept C2779489039 @default.
• W2117697211 hasConcept C2779631663 @default.
• W2117697211 hasConcept C2781253189 @default.
• W2117697211 hasConcept C3019249092 @default.
• W2117697211 hasConcept C501593827 @default.
• W2117697211 hasConcept C523546767 @default.
• W2117697211 hasConcept C54355233 @default.
• W2117697211 hasConcept C547475151 @default.
• W2117697211 hasConcept C55493867 @default.
• W2117697211 hasConcept C64778159 @default.
• W2117697211 hasConcept C86803240 @default.
• W2117697211 hasConcept C89423630 @default.
• W2117697211 hasConcept C94665300 @default.
• W2117697211 hasConceptScore W2117697211C104317684 @default.
• W2117697211 hasConceptScore W2117697211C185592680 @default.
• W2117697211 hasConceptScore W2117697211C2776968632 @default.
• W2117697211 hasConceptScore W2117697211C2777050379 @default.
• W2117697211 hasConceptScore W2117697211C2777058267 @default.
• W2117697211 hasConceptScore W2117697211C2777402170 @default.
• W2117697211 hasConceptScore W2117697211C2777637488 @default.
• W2117697211 hasConceptScore W2117697211C2778709256 @default.
• W2117697211 hasConceptScore W2117697211C2778719061 @default.
• W2117697211 hasConceptScore W2117697211C2778752919 @default.
• W2117697211 hasConceptScore W2117697211C2779489039 @default.
• W2117697211 hasConceptScore W2117697211C2779631663 @default.
• W2117697211 hasConceptScore W2117697211C2781253189 @default.
• W2117697211 hasConceptScore W2117697211C3019249092 @default.
• W2117697211 hasConceptScore W2117697211C501593827 @default.
• W2117697211 hasConceptScore W2117697211C523546767 @default.
• W2117697211 hasConceptScore W2117697211C54355233 @default.
• W2117697211 hasConceptScore W2117697211C547475151 @default.
• W2117697211 hasConceptScore W2117697211C55493867 @default.
• W2117697211 hasConceptScore W2117697211C64778159 @default.
• W2117697211 hasConceptScore W2117697211C86803240 @default.
• W2117697211 hasConceptScore W2117697211C89423630 @default.
• W2117697211 hasConceptScore W2117697211C94665300 @default.
• W2117697211 hasIssue "3" @default.
• W2117697211 hasLocation W21176972111 @default.
• W2117697211 hasLocation W21176972112 @default.
• W2117697211 hasLocation W21176972113 @default.
• W2117697211 hasOpenAccess W2117697211 @default.
• W2117697211 hasPrimaryLocation W21176972111 @default.
• W2117697211 hasRelatedWork W2002142324 @default.
• W2117697211 hasRelatedWork W2019234048 @default.
• W2117697211 hasRelatedWork W2041753995 @default.
• W2117697211 hasRelatedWork W2064473343 @default.
• W2117697211 hasRelatedWork W2091190156 @default.
• W2117697211 hasRelatedWork W2117697211 @default.
• W2117697211 hasRelatedWork W2143324329 @default.
• W2117697211 hasRelatedWork W2145014975 @default.
• W2117697211 hasRelatedWork W2145679126 @default.
• W2117697211 hasRelatedWork W2167859875 @default.
• W2117697211 hasVolume "37" @default.
• W2117697211 isParatext "false" @default.
• W2117697211 isRetracted "false" @default.
• W2117697211 magId "2117697211" @default.
• W2117697211 workType "article" @default.